Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15480238 | 0.98 | PDK2 (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL16596659 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL13444286 | 0.94 | KDM4E (0.36) | KDM4EATML3MBTL1LMNAHPGD | |
| SCHEMBL19653101 | 0.94 | KDM4E (0.32) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL19653099 | 0.94 | KDM4E (0.32) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL13444270 | 0.93 | KDM4E (0.35) | KDM4EATML3MBTL1LMNAHPGD | |
| SCHEMBL13566756 | 0.93 | KDM4E (0.35) | KDM4EATML3MBTL1LMNAHPGD | |
| SCHEMBL23468762 | 0.93 | KDM4E (0.33) | KDM4EATML3MBTL1LMNASMN1; SMN2 | |
| SCHEMBL17178660 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL20277454 | 0.92 | KDM4E (0.37) | KDM4EATML3MBTL1MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
| US-RE49237-E1 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2022-10-04 | — | — | US | disclosed |
| EP-3863077-B1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2022-05-04 | — | — | EP | disclosed |
| EP-3863077-A1 | ORGANIC LIGHT EMITTING DIODE | LG Chem, Ltd. (KR) | 2021-08-11 | — | — | EP | disclosed |
| EP-3832746-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG Chem, Ltd. (KR) | 2021-06-09 | — | — | EP | disclosed |
| US-10707434-B2 | Organic electroluminescence element, and material for organic electroluminescence element | IDEMITSU KOSAN CO., LTD. (JP) | 2020-07-07 | — | — | US | disclosed |
| US-20190019972-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2019-01-17 | — | — | US | disclosed |
| US-20160268517-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20160268517-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
| US-9397307-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-9397307-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20150249219-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
| US-20150249219-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
| US-20140306207-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-10-16 | — | — | US | disclosed |
| US-20140231769-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20140231769-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20140048784-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2014-02-20 | — | — | US | disclosed |
| US-20140048784-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2014-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190019972-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | LEF1, L1CAM, AGO2 | KDM4E 3248/4885ATM 2324/4885L3MBTL1 1678/4885 |
| US-20160268517-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | L1CAM, CCNT1, CCNA1 | KDM4E 2191/4885ATM 4082/4885L3MBTL1 30/4885 |
| US-10707434-B2 | Organic electroluminescence element, and material for organic electroluminescence element | LEF1, L1CAM, AGO2 | KDM4E 3248/4885ATM 2324/4885L3MBTL1 1678/4885 |
| US-20150249219-A1 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | L1CAM, CCNT1, CCNA1 | KDM4E 2205/4885ATM 4082/4885L3MBTL1 29/4885 |
| US-20230049674-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, ELOVL1, CRY1 | KDM4E 2327/4885ATM 4301/4885L3MBTL1 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.